Pharmacy Times interviewed Erin McConnell, PharmD, program manager, pharmacy quality at the University of Pittsburgh Medical Center, on the factors impacting cholesterol treatment management decisions and emerging therapies for high-risk patients.Pharmacy Times: Can you discuss the clinical decision-making process for choosing between statins, PSCK9 inhibitors, or newer agents like inclisiran?McConnell: The cornerstone of therapy is a healthy lifestyle, which includes optimum weight, not…
Read More…